Syndemic conditions associated with hazardous alcohol consumption among sexual minority men in San Francisco
Drug and Alcohol Dependence Reports · 2024-12 · 13 · 100297
DOI: 10.1016/j.dadr.2024.100297 ↗Kurz gefasst
Fachartikel in der Zeitschrift Drug and Alcohol Dependence Reports, 2024-12. Verfasst von Thye Peng Ngo und 2 weiteren Autor:innen. Beteiligte Einrichtung: National Clinician Scholars Program at University of California, San Francisco, San Francisco, CA, United States. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIH HHS, NIAAA NIH HHS, NINR NIH HHS.
Abstract (Originalsprache)
Background
Hazardous alcohol consumption (HAC) is prevalent among sexual minority men (SMM). Using syndemic theory, this study aimed to identify the number of syndemic conditions, including their combinations, and their association with HAC among SMM in San Francisco.
Method
We conducted a secondary analysis of cross-sectional data from 246 SMM who consume alcohol. Syndemic factors included multiple substance use, depressive symptoms, HIV/STI status, and houselessness. We conducted a multivariable logistic regression to estimate the odds of HAC associated with increasing syndemic conditions. We further examined which combinations of three syndemic factors were associated with the highest odds for HAC.
Results
The average age was 40.7; participants were predominantly White (33.3 %) and Black/African American (29.7 %) and graduated from high school (92.7 %). The prevalence of HAC increased with the number of syndemic conditions: 13.6 % with none, 30.9 % with one, 51.9 % with two, 65.1 % with three, and 69.2 % with four conditions. A significant log-linear trend was observed, with two syndemic conditions increasing the odds of HAC over fivefold (AOR=5.05, 95 % CI=1.68-15.15), and three and four syndemic conditions increasing the odds by more than eightfold (AOR=8.82, 95 % CI=2.74-28.39; AOR=8.55, 95 % CI=2.26-32.28). The combination of depressive symptoms, HIV/STI status, and houselessness tripled the odds for HAC (OR=3.07, 95 % CI=1.34-7.04).
Conclusion
HAC was associated with increasing syndemics, and specific conditions (depression, HIV/STI, and houselessness) had the greatest odds of HAC. These findings underscore the need for comprehensive screening and integrated interventions targeting these co-occurring conditions to reduce HAC in this population.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- National Clinician Scholars Program at University of California, San Francisco, San Francisco, CA, United States.
- San Francisco Veterans Affairs Health Care System, San Francisco, CA, United States.
- School of Nursing, University of California, San Francisco, San Francisco, CA, United States.
- Division of Prevention Science, School of Medicine, University of California, San Francisco, CA, United States.
- Center for Public Health Research, San Francisco Department of Public Health, San Francisco, CA, United States.
Förderung
- NIH HHS
- NIAAA NIH HHS
- NINR NIH HHS
- National Institute on Alcohol Abuse and Alcoholism
- National Institute of Nursing Research
- National Institutes of Health
Zitieren
APA
Ngo, T. P., Cuffaro, T., & Santos, G. M. (2024). Syndemic conditions associated with hazardous alcohol consumption among sexual minority men in San Francisco. Drug and Alcohol Dependence Reports, 13, 100297. https://doi.org/10.1016/j.dadr.2024.100297
Vancouver
Ngo TP, Cuffaro T, Santos GM. Syndemic conditions associated with hazardous alcohol consumption among sexual minority men in San Francisco. Drug and Alcohol Dependence Reports. 2024;13:100297. doi:10.1016/j.dadr.2024.100297
BibTeX
@article{Ngo2024,
author = {Ngo, Thye Peng and Cuffaro, Taylor and Santos, Glenn-Milo},
title = {Syndemic conditions associated with hazardous alcohol consumption among sexual minority men in San Francisco},
journal = {Drug and Alcohol Dependence Reports},
year = {2024},
volume = {13},
pages = {100297},
doi = {10.1016/j.dadr.2024.100297}
}
EUVIMED